Table 6.
Disease
|
Ref.
|
Microbes
|
Sample
|
Role
|
Pancreatic cancer | Michaud et al[30] | A history of periodontal diseases | Risk factor | |
Farrell et al[28] | A combination of Neisseria elongate and Streptococcus mitis | Oral | Distinguishing from healthy controls | |
Torres et al[29] | Ratio of Leptotrichia to Porphyromonas | Saliva | Higher in pancreatic cancer patients | |
Fan et al[27] | Porphyromonas gingivalis | Oral, antibody | Risk factor | |
Olson et al[39] | Firmicutes | Oral | More abundant | |
Lu et al[40] | Leptotrichia, Fusobacterium, Rothia, Actinomyces, Corynebacterium, Atopobium, Peptostreptococcus, Catonella, Oribacterium, Filifactor, Campylobacter, Moraxella, Tannerella | Tongue coating | More prevalent | |
Mei et al[46] | Acinetobactor, Aquabacterium, Oceanobacillus, Rahnella, Massilia, Delftia, Deinococcus, Sphingobium | Duodenal mucosa | More abundant | |
Mitsuhashi et al[43] | Fusobacterium species | Cancer tissue | Poor prognosis | |
Riquelme et al[44] | Pseudoxanthomonas, Streptomyces, Saccharopolyspora, Bacillus clausii | Cancer tissue | Long-term survival | |
Pancreatic and ampullary cancer | Di Calro et al[45] | Escherichia coli, Klebsiella pneumoniae | Bile juice | Predictor for survival |
IPMN with high-grade dysplasia | Gaiser et al[47] | Granulicatella adiacens, Fusobacterium nucleatum | Cyst fluid | More abundant |
IPMN: Intraductal papillary mucinous neoplasm.